UTMD

Utah Medical Products Inc

Add to Watchlist

$

55.520

-0.5(-0.893%)1D

Overview
Forecast
Valuation
Earnings

Line

|

Candle

1D

5D

1M

3M

6M

YTD

1Y

5Y

High

55.980

Open

55.600

VWAP

55.60

Vol

19.16K

Mkt Cap

180.34M

Low

55.300

Amount

1.06M

EV/EBITDA(TTM)

6.18

Total Shares

3.53M

EV

97.02M

EV/OCF(TTM)

6.92

P/S(TTM)

4.84

Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

Show More

Valuation Metrics

The current forward P/E ratio for Utah Medical Products Inc (UTMD.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Utah Medical Products Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

FY2025Q1

YoY :

-14.37%

9.71M

Total Revenue

FY2025Q1

YoY :

-18.80%

3.15M

Operating Profit

FY2025Q1

YoY :

-23.13%

3.04M

Net Income after Tax

FY2025Q1

YoY :

-15.60%

0.92

EPS - Diluted

FY2025Q1

YoY :

-18.54%

4.28M

Free Cash Flow

FY2025Q1

YoY :

-4.41%

57.03

Gross Profit Margin - %

FY2025Q1

34.69

FCF Margin - %

FY2025Q1

YoY :

-10.23%

31.32

Net Margin - %

FY2025Q1

YoY :

-20.56%

10.59

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

0

3-6

Months

0.0

USD

0

6-9

Months

0.0

USD

0

0-12

Months

0.0

USD

0

Bought

0-3

0

0.0

USD

Months

3-6

0

0.0

USD

Months

6-9

0

0.0

USD

Months

0-12

0

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

0

3-6

Months

0.0

Volume

0

6-9

Months

1.9K

Volume

1

0-12

Months

0.0

Volume

0

Bought

0-3

0

0.0

Volume

Months

3-6

0

0.0

Volume

Months

6-9

0

0.0

Volume

Months

0-12

0

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

0

3-6

Months

0.0

USD

0

6-9

Months

0.0

USD

0

0-12

Months

0.0

USD

0

Bought

0-3

0

0.0

USD

Months

3-6

0

0.0

USD

Months

6-9

0

0.0

USD

Months

0-12

0

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

0

3-6

Months

0.0

USD

0

6-9

Months

0.0

USD

0

0-12

Months

0.0

USD

0

Bought

0-3

0

0.0

USD

Months

3-6

0

0.0

USD

Months

6-9

0

0.0

USD

Months

0-12

0

0.0

USD

Months

UTMD News & Events

Events Timeline

2025-04-29 (ET)

2025-04-29

09:20:59

Utah Medical Products reports Q1 EPS 92c vs. $1.09 last year

2024-11-05 (ET)

2024-11-05

09:05:31

Utah Medical Products appoints Carrie Leigh to board of directors

2024-11-05

09:04:44

Utah Medical board raises quarterly cash dividend by 1.7% to 30.5c per share

Sign Up For More Events

Sign Up For More Events

News

6.5

06-24NASDAQ.COM

Top Analyst Reports for JPMorgan, Novartis & AT&T

4.0

06-18NASDAQ.COM

Validea Benjamin Graham Strategy Daily Upgrade Report - 6/18/2025

6.5

04-01NASDAQ.COM

Top Research Reports for Verizon, The Southern Co. & Blackstone

Sign Up For More News

People Also Watch

San Juan Basin Royalty Trust

James River Group Holdings Ltd

Sophia Genetics SA

City Office REIT Inc

Digital Turbine Inc

A2Z Cust2Mate Solutions Corp

Gold Royalty Corp

Hawthorn Bancshares Inc

FAQ

What is Utah Medical Products Inc (UTMD) stock price today?

The current price of UTMD is 55.52 USD — it has decreased -0.89 % in the last trading day.

What is Utah Medical Products Inc (UTMD)'s business?

What is the price predicton of UTMD Stock?

What is Utah Medical Products Inc (UTMD)'s revenue for the last quarter?

What is Utah Medical Products Inc (UTMD)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Utah Medical Products Inc (UTMD)'s fundamentals?

How many employees does Utah Medical Products Inc (UTMD). have?

What is Utah Medical Products Inc (UTMD) market cap?